Gradient Investments »

Eagle Pharmaceuticals shares owned by Gradient Investments

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Gradient Investments from 13F filings

Historical chart of Gradient Investments investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by Gradient Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by Gradient Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $152 29 5.24
2023-09-30 $456 29 15.76
2023-06-30 $564 29 19.45

More positions owned by Gradient Investments

Spdr Ser Tr Portfolio S&p500 (SPLG)
Innovator Etfs Trust Gradient Tactic (IGTR)
Ishares Tr Ishs 5-10yr Invt (IGIB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Doubleline Etf Trust Mortgage Etf (DMBS)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Innovator Etfs Trust Us Eqty Bufr Feb (BFEB)
Microsoft Corporation (MSFT)
Innovator Etfs Trust Us Eqty Pwr Buf (PFEB)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Amazon (AMZN)
Goldman Sachs Etf Tr Future Consumer (GBUY)
Ssga Active Etf Tr Ult Sht Trm Bd (ULST)
Apple (AAPL)

View all positions for Gradient Investments

Top funds holding Eagle Pharmaceuticals

Henderson Group
Brandes Investment Partners
Vanguard Group
Millennium Management
AQR Capital Management
LSV Asset Management
J. Goldman & Co
Dimensional Fund Advisors
Two Sigma Advisers
Two Sigma Investments
Goldman Sachs Group
Thomas Stevens, CFA"
Bank of America Corporation
Assenagon Asset Management
D. E. Shaw & Co

View all funds holding Eagle Pharmaceuticals